Table 1 Patient characteristics after propensity score matching, stratified by diagnosis of bronchiectasis.
From: Characterization of bronchiectasis in lung cancer using German claims data
PRE bronchiectasis (n = 364) | PRE controls (n = 364) | stdiff | POST bronchiectasis (n = 208) | POST controls (n = 208) | stdiff | |||||
|---|---|---|---|---|---|---|---|---|---|---|
mean | sd | mean | sd | mean | sd | mean | sd | |||
Age | 70.0 | 10.3 | 69.7 | 10.1 | 0.03 | 68.2 | 9.4 | 69.0 | 9.1 | 0.09 |
CCI score | 3.4 | 2.19 | 3.1 | 2.24 | 0.14 | 2.8 | 2.08 | 2.6 | 2.09 | 0.06 |
n | % | n | % | stdiff | n | % | n | % | stdiff | |
Sex | ||||||||||
Male | 258 | 70.9% | 258 | 70.9% | 155 | 74.5% | 163 | 78.4% | ||
Female | 106 | 29.1% | 106 | 29.1% | 0.00 | 53 | 25.5% | 45 | 21.6% | 0.09 |
Metastases status at diagnosis | ||||||||||
N0,M0 & diagnostic | 140 | 38.5% | 141 | 38.7% | 66 | 31.7% | 68 | 32.7% | ||
N0,M0 & no diagnostic | 27 | 7.4% | 26 | 7.1% | 28 | 13.5% | 28 | 13.5% | ||
N1,N2,N3 | 57 | 15.7% | 57 | 15.7% | 45 | 21.6% | 42 | 20.2% | ||
Ma | 34 | 9.3% | 34 | 9.3% | 23 | 11.1% | 20 | 9.6% | ||
Mb, Mc | 106 | 29.1% | 106 | 29.1% | 0.01 | 46 | 22.1% | 50 | 24.0% | 0.07 |
Regional type of residence | ||||||||||
Major city | 116 | 31.9% | 115 | 31.6% | 63 | 30.3% | 67 | 32.2% | ||
Urban | 119 | 32.7% | 119 | 32.7% | 80 | 38.5% | 80 | 38.5% | ||
Rural | 70 | 19.2% | 71 | 19.5% | 40 | 19.2% | 40 | 19.2% | ||
Remote rural | 59 | 16.2% | 59 | 16.2% | 0.01 | 25 | 12.0% | 21 | 10.1% | 0.07 |
Unknown | ||||||||||
Hospital size (# of lung cancer patients) | ||||||||||
Fewer than 50 | 40 | 11.0% | 40 | 11.0% | 14 | 6.7% | 10 | 4.8% | ||
50–99 | 51 | 14.0% | 51 | 14.0% | 26 | 12.5% | 26 | 12.5% | ||
100–199 | 109 | 29.9% | 110 | 30.2% | 66 | 31.7% | 68 | 32.7% | ||
200–299 | 71 | 19.5% | 71 | 19.5% | 38 | 18.3% | 41 | 19.7% | ||
300–399 | 55 | 15.1% | 54 | 14.8% | 42 | 20.2% | 38 | 18.3% | ||
400 and more | 38 | 10.4% | 38 | 10.4% | 0.01 | 22 | 10.6% | 25 | 12.0% | 0.11 |
Unknown | ||||||||||
Comorbidities | ||||||||||
Myocardial infarction | 47 | 12.9% | 53 | 14.6% | 0.05 | 17 | 8.2% | 26 | 12.5% | 0.14 |
Congestive heart disease | 118 | 32.4% | 118 | 32.4% | 0.00 | 48 | 23.1% | 43 | 20.7% | 0.06 |
Peripheral vascular disease | 143 | 39.3% | 144 | 39.6% | 0.01 | 75 | 36.1% | 82 | 39.4% | 0.07 |
Cerebrovascular disease | 81 | 22.3% | 79 | 21.7% | 0.01 | 40 | 19.2% | 31 | 14.9% | 0.12 |
dementia | 24 | 6.6% | 21 | 5.8% | 0.03 | 13 | 6.3% | 12 | 5.8% | 0.02 |
Chronic pulmonary disease | 316 | 86.8% | 212 | 58.2% | 0.68 | 140 | 67.3% | 117 | 56.3% | 0.23 |
Rheumatoid arthritis | 15 | 4.1% | 21 | 5.8% | 0.08 | 11 | 5.3% | 9 | 4.3% | 0.05 |
Peptic ulcer disease | 18 | 4.9% | 18 | 4.9% | 0.00 | 10 | 4.8% | 7 | 3.4% | 0.07 |
Mild liver disease | 74 | 20.3% | 64 | 17.6% | 0.07 | 41 | 19.7% | 33 | 15.9% | 0.10 |
Diabetes without complication | 119 | 32.7% | 122 | 33.5% | 0.02 | 59 | 28.4% | 68 | 32.7% | 0.09 |
Diabetes with complication | 79 | 21.7% | 79 | 21.7% | 0.00 | 33 | 15.9% | 33 | 15.9% | 0.00 |
Hemi- & paraplegia | 18 | 4.9% | 18 | 4.9% | 0.00 | 2 | 1.0% | 2 | 1.0% | 0.00 |
renal disease | 77 | 21.2% | 75 | 20.6% | 0.01 | 36 | 17.3% | 29 | 13.9% | 0.09 |
Prior cancer | 83 | 22.8% | 63 | 17.3% | 0.14 | 34 | 16.3% | 47 | 22.6% | 0.16 |
Mild to severe liver disease | 5 | 1.4% | 6 | 1.6% | 0.02 | 3 | 1.4% | 1 | 0.5% | 0.10 |
Prior metastatic cancer | 35 | 9.6% | 26 | 7.1% | 0.09 | 16 | 7.7% | 8 | 3.8% | 0.17 |
HIV/AIDS | 0 | 0.0% | 1 | 0.3% | 0.07 | 0 | 0.0% | 0 | 0.0% | 0.00 |
